While recurrent oncogenic lesions in BRAF (pV600) and N/K/HRAS (pG12/13, p.Q61) predominate within the RAS-MAPK pathway, they are rarely identified in conjunction within any single tumor specimen [3, 4]. The gene discussed is BRAF; the disease is neoplasm.